Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 791-799
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.791
Table 1 Annual number of patients with Wilson disease
Calendar yearPatients with WD in the database
201611887
20172239
20182253
20192356
20202220
20212277
Table 2 Clinical manifestations during follow-up
Type of manifestationAll patients
Patients with documented treatment
Patients with no documented treatment
P value by χ² test
n = 5376
n = 885
n = 4491
Hepatic manifestations1796 (33.4)389 (44.0)1288 (28.7)< 0.001
Neurological manifestations1935 (36.0)302 (34.1)1577 (35.1)0.572
Psychiatric manifestations2433 (45.3)383 (43.3)1977 (44.0)0.683
At least one of the above3829 (71.2)649 (73.3)3060 (68.1)0.002
Table 3 Hospitalisations
ParameterAll patients
Patients with documented treatment
Patients with no documented treatment
P value by χ² test
n = 5376
n = 885
n = 4491
Day hospitalisations, n (%)4991 (92.8)865 (97.7)4126 (91.9)< 0.0001
Overnight hospitalisations, n (%)1564 (29.1)295 (33.3)1269 (28.3)0.0023
Length of stay1, median (IQR)6 (2–16)6 (2–17)6 (2–17)NA
Liver transplantation, n (%)121 (2.3)23 (2.6)98 (2.2)NA
Table 4 Mortality
Insurees with WD
All insurees
Year
Total n
Deaths
Mortality rate, %
Total n
Deaths
Mortality rate, %
201611887271.4320306088219912150.98
20172239512.2822331380123412971.05
20182253582.5722382896224202971.08
20192356612.5921908801123900491.09
20202220632.8421545762924616271.14
202122277130.572391642642053130.09
Total53762735.08431039425118097982.74